New AI tool uses gene activity patterns to predict cancer spread, helping doctors identify high-risk patients and personalize ...
A new form of CAR T kills leukemia, multiple myeloma, and sarcoma in mice, opening the door to a future off-the-shelf cancer ...
OverT Bio forms Clinical Advisory Board to advance OVT-101, a scalable CAR-T therapy targeting CLDN6 for ovarian and other solid tumors.
UCLA and Stanford Medicine researchers, in collaboration with scientists from the University of Utah and Columbia University, ...
Researchers have discovered that cancer spread isn’t random—it follows a kind of biological “program.” By studying colon ...
T cells are supposed to be relentless. These white blood cells patrol the body, identify threats, and destroy them.
The Nanomedicine and Nanotoxicology Group (GNano) at the University of São Paulo's São Carlos Institute of Physics (IFSC-USP) ...
Recent data suggests people taking GLP-1 drugs may develop colorectal cancer less often than those taking aspirin, a ...
Medicus Pharma (NASDAQ:MDCX) said on Monday that new analysis of data from a mid-stage clinical trial of its SkinJect microneedle therapy showed encouraging results in treating basal cell carcinoma, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results